United States - English - NLM (National Library of Medicine)

king bio inc, - adenosine cyclic phosphate (unii: e0399ozs9n) (adenosine cyclic phosphate - unii:e0399ozs9n), epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh), corticotropin (unii: k0u68q2txa) (corticotropin - unii:k0u68q2txa), hyacinthoides non-scripta (unii: 5f658pfu56) (hyacinthoides non-scripta - unii:5f658pfu56), onion (unii: 492225q21h) (onion - unii:492225q21h), collinsonia canadensis root (unii: o2630f3xdr) (collinsonia canadensis root - unii:o2630f3xdr), cortisone acetate (unii: 883wkn7w8x) (c - adenosine cyclic phosphate 12 [hp_x] in 59 ml - uses for temporary relief of allergy symptoms commonly experienced in ct. dc. de. ma. me, md. nh. nj. ny. pa. ri. vt. - itchy, watery eyes - runny nose - sneezing - sore throat - sinus congestion - cough - stuffy nose - fatigue - itchy, irritated skin - hoarseness - headache drug facts __________________________________________________________________________________________________________ hpus active ingredients                                                       purpose equal volumes ofeach ingredient in 12x, 30x, and lm1 potencies. adenosinum cyclophosphoricum.............................................headache, runny nose adrenalinum........................................................................hay fever, swollen sinuses, lung congestion adrenocorticotrophin (30x)....................................................congestion, cough agraphis nutans....................................................................swollen glands or tonsils allium cepa.........................................

United States - English - NLM (National Library of Medicine)

native remedies, llc - adenosine cyclic phosphate (unii: e0399ozs9n) (adenosine cyclic phosphate - unii:e0399ozs9n), epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh), corticotropin (unii: k0u68q2txa) (corticotropin - unii:k0u68q2txa), hyacinthoides non-scripta (unii: 5f658pfu56) (hyacinthoides non-scripta - unii:5f658pfu56), onion (unii: 492225q21h) (onion - unii:492225q21h), collinsonia canadensis root (unii: o2630f3xdr) (collinsonia canadensis root - unii:o2630f3xdr), cortisone acetate (unii: 883wkn7w8x) ( - adenosine cyclic phosphate 12 [hp_x] in 59 ml - relieves allergies common in the northeastern u.s. uses: for temporary relief of symptoms: itchy, watery eyes, sore throat, cough, runny nose, sneezing, congestion, headaches, hoarseness, and fatigue

United States - English - NLM (National Library of Medicine)

king bio inc. - equal volumes of each hpus ingredient in 12x, 30x, and 1lm potencies., adenosinum cyclophosphoricum, adrenalinum, adrenocorticotrophin (30x), agraphis nutans, allium cepa, arum triphyllum, arundo mauritanica, collinsonia canadensis, cortisone aceticum, euphrasia officinalis, galphimia glauca, histaminum hydrochloricum,kali muriaticum,  natrum muriaticum,  rna,  rumex crispus,  sabadilla,  salvia officinalis,  tanacetum vulgare,  trifolium pratense and  vinca minor., **“hpus” indicates the active ingredients - for temporary relief of allergy symptoms commonly experienced in ct, dc, de, ma, md, me, nh, nj, ny, pa, ri, vt: itchy, watery eyes runny nose sneezing sore throat sinus congestion  cough  stuffy nose  fatigue itchy, irritated skin  hoarseness  headache  † as per various homeopathic materia medicas. claims based on traditional homeopathic practice, not accepted medical evidence. these uses have not been evaluated by the fda, and product has not been clinically tested. reference image: northeastern.jpg  adenosinum cyclophosphoricum..............headache, runny nose adrenalinum ........... hay fever, swollen sinuses, lung congestion adrenocorticotrophin (30x) ............................congestion, cough agraphis nutans ................................... swollen glands or tonsils allium cepa........................hay fever, sinus headache, sneezing arum triphyllum ..........inflammation of nasal mucus membranes arundo mauritanica ........................nasal congestion and itching collinsonia cana

United States - English - NLM (National Library of Medicine)

king bio inc. - adenosinum cyclophosphoricum, adrenalinum, adrenocorticotrophin (30x, 100x), agraphis, allium cepa, arum triph, arundo mauritanica, collinsonia, cortisone aceticum, euphrasia, galphimia, histaminum hydrochloricum, kali mur, nat mur, rna, rumex crisp, sabadilla, salvia, tanacetum, trifolium prat, vinca., equal volumes of each hpus ingredient in 12x, 30x, 100x, 1lm, 2lm, 3lm, 5lm potencies., reference image: northeast.jpg - for temporary relief of symptoms: red, itchy, watery eyes, sore throat, cough, runny nose, sneezing, congestion, headaches, hoarseness, & fatigue. reference image: northeast.jpg uses for temporary relief of symptoms: red, itchy,  watery eyes sore throat cough runny nose sneezing congestion headaches hoarseness fatigue refernce image: northeast.jpg

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine 3 mg in 1 ml - adenosine injection is indicated for the following. conversion to sinus rhythm of paroxysmal supraventricular tachycardia (psvt), including that associated with accessory bypass tracts (wolff-parkinson-white syndrome). when clinically advisable, appropriate vagal maneuvers (e.g., valsalva maneuver), should be attempted prior to adenosine administration. it is important to be sure the adenosine solution actually reaches the systemic circulation (see dosage and administration). adenosine does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. in the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine administration. adenosine injection is contraindicated in: - second- or third-degree a-v block (except in patients with a functioning artificial pacemaker). - sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning arti

United States - English - NLM (National Library of Medicine)

akorn - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine 3 mg in 1 ml - adenosine injection is indicated for the following. conversion to sinus rhythm of paroxysmal supraventricular tachycardia (psvt), including that associated with accessory bypass tracts (wolff-parkinson-white syndrome). when clinically advisable, appropriate vagal maneuvers (e.g., valsalva maneuver), should be attempted prior to adenosine administration. it is important to be sure the adenosine solution actually reaches the systemic circulation (see dosage and administration ). adenosine does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. in the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine administration. adenosine injection is contraindicated in: - second- or third-degree a-v block (except in patients with a functioning artificial pacemaker). - sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning artificial pacemaker). - known hypersensitivity to adenosine.

United States - English - NLM (National Library of Medicine)

cardinal health - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine 3 mg in 1 ml - adenosine injection is indicated for the following. conversion to sinus rhythm of paroxysmal supraventricular tachycardia (psvt), including that associated with accessory bypass tracts (wolff-parkinson-white syndrome). when clinically advisable, appropriate vagal maneuvers (e.g., valsalva maneuver), should be attempted prior to adenosine administration. it is important to be sure the adenosine solution actually reaches the systemic circulation (see dosage and administration ). adenosine does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. in the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine administration. adenosine injection is contraindicated in:

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine 3 mg in 1 ml - adenosine injection is indicated for the following. conversion to sinus rhythm of paroxysmal supraventricular tachycardia (psvt), including that associated with accessory bypass tracts (wolff-parkinson-white syndrome). when clinically advisable, appropriate vagal maneuvers (e.g., valsalva maneuver), should be attempted prior to adenosine administration. it is important to be sure the adenosine solution actually reaches the systemic circulation (see dosage and administration ). adenosine does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. in the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine administration. adenosine injection is contraindicated in: - second- or third-degree a-v block (except in patients with a functioning artificial pacemaker). - sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning art

United States - English - NLM (National Library of Medicine)

heritage pharmaceuticals inc. - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine 3 mg in 1 ml - adenosine injection, usp is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately. adenosine injection is contraindicated in patients with: - second- or third-degree av block (except in patients with a functioning artificial pacemaker) [seewarnings and precautions (5.2) ] - sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning artificial pacemaker) [see warnings and precautions (5.2)] - known or suspected bronchoconstrictive or bronchospastic lung disease (e.g., asthma) [see warnings and precautions (5.3)] - known hypersensitivity to adenosine [seewarnings and precautions (5.7)] pregnancy category c. animal reproduction studies have not been conducted with adenosine; nor have studies been performed in pregnant women. because it is not known whether adenosine injection can cause fetal harm when administered to pregnant women, adenosine injection should be used during pregnancy only if clea

United States - English - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine 3 mg in 1 ml - adenosine injection, usp is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately. adenosine injection is contraindicated in patients with: - second- or third-degree av block (except in patients with a functioning artificial pacemaker) [see warnings and precautions (5.2)] - sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning artificial pacemaker) [see warnings and precautions (5.2)] - known or suspected bronchoconstrictive or bronchospastic lung disease (e.g., asthma) [see warnings and precautions (5.3)] - known hypersensitivity to adenosine [see warnings and precautions (5.7)] pregnancy category c. animal reproduction studies have not been conducted with adenosine; nor have studies been performed in pregnant women. because it is not known whether adenosine injection can cause fetal harm when administered to pregnant women, adenosine injection should be used during pregnancy only if cle